These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26461468)

  • 1. Impact of Humidity on In Vitro Human Skin Permeation Experiments for Predicting In Vivo Permeability.
    Ishida M; Takeuchi H; Endo H; Yamaguchi JI
    J Pharm Sci; 2015 Dec; 104(12):4223-4231. PubMed ID: 26461468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in skin mimic systems to predict transdermal permeation.
    Waters LJ
    Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.
    Yamamoto S; Karashima M; Sano N; Fukushi C; Tohyama K; Arai Y; Hirabayashi H; Amano N
    Pharm Res; 2017 Nov; 34(11):2415-2424. PubMed ID: 28828717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.
    Van Gele M; Geusens B; Brochez L; Speeckaert R; Lambert J
    Expert Opin Drug Deliv; 2011 Jun; 8(6):705-20. PubMed ID: 21446890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in predicting skin permeability of hydrophilic solutes.
    Chen L; Han L; Lian G
    Adv Drug Deliv Rev; 2013 Feb; 65(2):295-305. PubMed ID: 22580335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the skin permeation barrier: challenges and opportunities.
    Vitorino C; Sousa J; Pais A
    Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Microneedle Arrays for Enhancement of Transdermal Permeation of Insulin: In Vitro Experiments, Scaling Analyses and Numerical Simulations.
    Leeladurga V; Teja UC; Sultana SK; Sudeep K; Anusha VS; Han T; Nalluri BN; Das DB
    AAPS PharmSciTech; 2016 Aug; 17(4):915-22. PubMed ID: 26729523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear free energy relationship analysis of permeability across polydimethylsiloxane (PDMS) membranes and comparison with human skin permeation in vitro.
    Liu X; Zhang K; Abraham MH
    Eur J Pharm Sci; 2018 Oct; 123():524-530. PubMed ID: 30107227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Human Pharmacokinetic Profile After Transdermal Drug Application Using Excised Human Skin.
    Yamamoto S; Karashima M; Arai Y; Tohyama K; Amano N
    J Pharm Sci; 2017 Sep; 106(9):2787-2794. PubMed ID: 28315690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities in dermal/transdermal delivery.
    Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
    Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.